These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17785798)

  • 1. Molecular determinants of inverse agonist activity of biologicals targeting CTLA-4.
    Teft WA; Madrenas J
    J Immunol; 2007 Sep; 179(6):3631-7. PubMed ID: 17785798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
    Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
    J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation.
    Darlington PJ; Kirchhof MG; Criado G; Sondhi J; Madrenas J
    J Immunol; 2005 Jul; 175(2):996-1004. PubMed ID: 16002699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of oligomers induced by inverse agonists of CTLA-4.
    Teft WA; Madrenas J
    Immunol Lett; 2008 Oct; 120(1-2):29-36. PubMed ID: 18634825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7-independent inhibition of T cells by CTLA-4.
    Chikuma S; Abbas AK; Bluestone JA
    J Immunol; 2005 Jul; 175(1):177-81. PubMed ID: 15972645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of T cell anergy in the absence of CTLA-4/B7 interaction.
    Frauwirth KA; Alegre ML; Thompson CB
    J Immunol; 2000 Mar; 164(6):2987-93. PubMed ID: 10706686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression.
    Chuang E; Alegre ML; Duckett CS; Noel PJ; Vander Heiden MG; Thompson CB
    J Immunol; 1997 Jul; 159(1):144-51. PubMed ID: 9200449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse.
    Pentcheva-Hoang T; Egen JG; Wojnoonski K; Allison JP
    Immunity; 2004 Sep; 21(3):401-13. PubMed ID: 15357951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic equilibrium of B7-1 dimers and monomers differentially affects immunological synapse formation and T cell activation in response to TCR/CD28 stimulation.
    Bhatia S; Sun K; Almo SC; Nathenson SG; Hodes RJ
    J Immunol; 2010 Feb; 184(4):1821-8. PubMed ID: 20065109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
    J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
    Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
    J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
    Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28-independent costimulation of T cells in alloimmune responses.
    Yamada A; Kishimoto K; Dong VM; Sho M; Salama AD; Anosova NG; Benichou G; Mandelbrot DA; Sharpe AH; Turka LA; Auchincloss H; Sayegh MH
    J Immunol; 2001 Jul; 167(1):140-6. PubMed ID: 11418642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA-4 is a second receptor for the B cell activation antigen B7.
    Linsley PS; Brady W; Urnes M; Grosmaire LS; Damle NK; Ledbetter JA
    J Exp Med; 1991 Sep; 174(3):561-9. PubMed ID: 1714933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.
    Boussiotis VA; Freeman GJ; Gribben JG; Daley J; Gray G; Nadler LM
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11059-63. PubMed ID: 7504293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: tyrosine-independent transmission of inhibitory signals by CTLA-4.
    Cinek T; Sadra A; Imboden JB
    J Immunol; 2000 Jan; 164(1):5-8. PubMed ID: 10604984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A theoretical framework for quantitative analysis of the molecular basis of costimulation.
    Jansson A; Barnes E; Klenerman P; Harlén M; Sørensen P; Davis SJ; Nilsson P
    J Immunol; 2005 Aug; 175(3):1575-85. PubMed ID: 16034096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of CTLA-4 from inhibitor to activator of T cells with a bispecific tandem single-chain Fv ligand.
    Madrenas J; Chau LA; Teft WA; Wu PW; Jussif J; Kasaian M; Carreno BM; Ling V
    J Immunol; 2004 May; 172(10):5948-56. PubMed ID: 15128776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of murine CTLA-4 and its role in modulating T cell responsiveness.
    Ostrov DA; Shi W; Schwartz JC; Almo SC; Nathenson SG
    Science; 2000 Oct; 290(5492):816-9. PubMed ID: 11052947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular capture of B7 in antigen-presenting cells reduces costimulatory activity.
    Sheriff A; Vogt B; Baumgart M; Montag C; Hollenbach B; Schenk JA; Ulrich J; Elías F; Micheel B
    Biochem Biophys Res Commun; 2003 Feb; 301(4):873-8. PubMed ID: 12589793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.